摘要
背景:地佐辛是一种阿片类镇痛药,可影响免疫系统。在这里,我们探索了高浓度地佐辛和程序性死亡配体1 (PD-L1)在肺癌(LC)免疫逃逸和糖代谢中的协同作用。 方法:测定人LC细胞系中PD-L1的水平,并观察不同浓度地佐辛对LC细胞增殖的影响。接下来,通过转染LC细胞改变PD-L1水平,并以8 μg/mL的剂量暴露于地佐辛,探讨其对细胞增殖、干扰素-γ (IFN-γ)的产生、葡萄糖、乳酸和NADPH/NADP+含量以及核因子-κB (NF-κB)通路活化的影响。 结果:LC细胞中PD-L1水平升高,地佐辛(8 μg/mL)可抑制LC细胞的增殖。下调PD-L1可抑制细胞增殖,促进IFN-γ的产生,降低葡萄糖、乳酸和NADPH/NADP+含量,上调PD-L1则相反。地佐辛(8 μg/mL)诱导LC的免疫逃逸和糖代谢,下调PD-L1可逆转地佐辛诱导的作用。地佐辛(8 μg/mL)通过激活NF-κB通路上调PD-L1。 结论:8 μg/mL地佐辛通过上调PD-L1,激活NF-κB通路,促进LC的免疫逸出和糖代谢。
关键词: 肺癌,地佐辛,程序性死亡配体1,核因子-κB通路,增殖,免疫逃逸,葡萄糖消耗。
[http://dx.doi.org/10.1016/j.mcna.2018.12.006] [PMID: 30955514]
[http://dx.doi.org/10.1016/j.ccm.2019.10.001] [PMID: 32008623]
[http://dx.doi.org/10.1016/j.cnc.2019.05.002] [PMID: 31351552]
[http://dx.doi.org/10.7861/clinmedicine.18-2-s41] [PMID: 29700092]
[http://dx.doi.org/10.1016/S0140-6736(16)30958-8] [PMID: 27574741]
[http://dx.doi.org/10.2174/1566524018666180222114038] [PMID: 29473504]
[http://dx.doi.org/10.1111/bph.13903] [PMID: 28593737]
[PMID: 31539162]
[http://dx.doi.org/10.3892/ol.2019.9964] [PMID: 30867775]
[http://dx.doi.org/10.21037/atm.2020.03.28] [PMID: 32395524]
[http://dx.doi.org/10.1016/j.intimp.2019.106088] [PMID: 31896512]
[http://dx.doi.org/10.1186/s12943-019-1073-4] [PMID: 31747941]
[http://dx.doi.org/10.5761/atcs.oa.18-00163] [PMID: 30282880]
[http://dx.doi.org/10.3389/fimmu.2020.584626] [PMID: 33324403]
[http://dx.doi.org/10.1016/j.biopha.2017.04.001] [PMID: 28415048]
[http://dx.doi.org/10.1158/0008-5472.CAN-20-1158] [PMID: 32816854]
[http://dx.doi.org/10.1016/j.molcel.2018.10.034] [PMID: 30527665]
[http://dx.doi.org/10.1038/s41420-021-00401-7] [PMID: 33462221]
[http://dx.doi.org/10.1186/s12964-019-0391-x] [PMID: 31382969]
[http://dx.doi.org/10.1002/j.1552-4604.1986.tb03550.x] [PMID: 2942579]
[http://dx.doi.org/10.1007/s10637-020-00921-6] [PMID: 32170576]
[http://dx.doi.org/10.4049/jimmunol.1801199] [PMID: 30979816]
[http://dx.doi.org/10.1158/0008-5472.CAN-18-3842] [PMID: 30808674]
[http://dx.doi.org/10.1038/s12276-019-0295-2] [PMID: 31399559]
[http://dx.doi.org/10.1016/j.biopha.2019.109790] [PMID: 31896065]
[http://dx.doi.org/10.1186/s13046-019-1394-6] [PMID: 31533774]
[http://dx.doi.org/10.3892/or.2020.7477] [PMID: 32020232]
[http://dx.doi.org/10.1038/s41388-018-0252-x] [PMID: 29706653]
[http://dx.doi.org/10.1002/jcb.27329] [PMID: 30145830]
[http://dx.doi.org/10.1039/C9FO02166C] [PMID: 31830168]